% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Pasquier:277942,
      author       = {D. Pasquier and L. Bidaut and D. E. Oprea-Lager and N. M.
                      deSouza and D. Krug and L. Collette and W. Kunz and Y.
                      Belkacemi and M. G. Bau and C. Caramella and L.-F. De
                      Geus-Oei and A. De Caluwé and C. Deroose and O. Gheysens
                      and K. Herrmann$^*$ and I. Kindts and M. Kontos and S.
                      Kümmel and B. Linderholm and E. Lopci and I. Meattini and
                      A. Smeets and O. Kaidar-Person and P. Poortmans and P.
                      Tsoutsou and N. Hajjaji and N. Russell and E. Senkus and
                      J.-N. Talbot and L. Umutlu and V. Vandecaveye and J. J. C.
                      Verhoeff and W. M. d. H. van Oordt and H. D. Zacho and F.
                      Cardoso and L. Fournier and F. Van Duijnhoven and F. E.
                      Lecouvet},
      title        = {{D}esigning clinical trials based on modern imaging and
                      metastasis-directed treatments in patients with
                      oligometastatic breast cancer: a consensus recommendation
                      from the {EORTC} {I}maging and {B}reast {C}ancer {G}roups.},
      journal      = {The lancet / Oncology},
      volume       = {24},
      number       = {8},
      issn         = {1470-2045},
      address      = {London},
      publisher    = {The Lancet Publ. Group},
      reportid     = {DKFZ-2023-01585},
      pages        = {e331 - e343},
      year         = {2023},
      abstract     = {Breast cancer remains the most common cause of cancer death
                      among women. Despite its considerable histological and
                      molecular heterogeneity, those characteristics are not
                      distinguished in most definitions of oligometastatic disease
                      and clinical trials of oligometastatic breast cancer. After
                      an exhaustive review of the literature covering all aspects
                      of oligometastatic breast cancer, 35 experts from the
                      European Organisation for Research and Treatment of Cancer
                      Imaging and Breast Cancer Groups elaborated a Delphi
                      questionnaire aimed at offering consensus recommendations,
                      including oligometastatic breast cancer definition, optimal
                      diagnostic pathways, and clinical trials required to
                      evaluate the effect of diagnostic imaging strategies and
                      metastasis-directed therapies. The main recommendations are
                      the introduction of modern imaging methods in metastatic
                      screening for an earlier diagnosis of oligometastatic breast
                      cancer and the development of prospective trials also
                      considering the histological and molecular complexity of
                      breast cancer. Strategies for the randomisation of imaging
                      methods and therapeutic approaches in different subsets of
                      patients are also addressed.},
      subtyp        = {Review Article},
      cin          = {ED01},
      ddc          = {610},
      cid          = {I:(DE-He78)ED01-20160331},
      pnm          = {899 - ohne Topic (POF4-899)},
      pid          = {G:(DE-HGF)POF4-899},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:37541279},
      doi          = {10.1016/S1470-2045(23)00286-3},
      url          = {https://inrepo02.dkfz.de/record/277942},
}